Sanford's Oxgaard on Hurdles to the Bayer-Monsanto Deal(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, on Bayer's sweetened bid for Monsanto, as Monsanto mulls options. See omnystudio.com/listener for privacy information.